+44 207 488 9947
legal issues in relation to
Our phenomenal diseases team will advise and assist your biopharma company engaged in the research & development, diagnosis, treatment, manufacturing and supply of medicines for diseases.
Our outstanding diseases team comprises lawyers, scientists and regulatory experts with knowledge and insight into the life sciences and pharmaceuticals sectors. Our diseases team also comprises scientists with doctorates and postdocs who have first-hand experience conducting research as well as working in the pharmaceutical, biotechnology and life sciences industry sectors. Accordingly, our highly skilled multidisciplinary legal and regulatory diseases team has great insight into the legal and regulatory landscape applicable to diseases and the demand for new drug discovery.
Our diseases lawyers will advise and assist you whether you are a pharmaceutical, a small and medium biotechnology or IT company involved in the diagnosis, treatment, manufacture and supply of medicines and vaccines for diseases.
We have focussed below on chronic, infectious and rare diseases:
Chronic Diseases
Our phenomenal diseases team will advise and assist your biopharma company engaged in the research & development, diagnosis, treatment, manufacturing and supply of medicines for chronic diseases. The trend is towards applying digitally enabled healthcare in personalised treatments for patients with chronic diseases.
Our chronic diseases team will advise and assist your company during the development of new medicines and vaccines to combat the growing threat of chronic diseases, the development of new delivery models and the application of genomics to develop medicines. A chronic diseases lawyer will provide you with legal advice if you are conducting innovative research into the prevention and control of chronic diseases.
Our chronic diseases team is experienced in advising the biopharmaceutical sector and is able to provide you with expert legal services pertaining to the development of new models to manage chronic diseases, the development and use of apps and Artificial Intelligence (AI) solutions to the monitoring, treatment and management of chronic diseases.
|
Infectious Diseases
Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi. As a result of an increase in new infections especially air borne viral infections, one of the major issues facing pharmaceutical and biotechnology companies in drug development for the treatment of infectious diseases is antimicrobial resistance.
Our outstanding infectious diseases team is able to advise biopharmaceutical companies on a number of specialist areas including:
|
Rare Diseases
Our leading diseases team will advise and assist your pharma and biotechnology companies in the research & development, diagnosis, treatment, manufacturing and supply of medicines for rare diseases.
Our law firm has an elite rare diseases team that appreciates that there are many conditions with currently no treatment and that there is still a lack of epidemiological, clinical and health economics data for most rare diseases. There is clearly reduced access to rare diseases medicines such as orphan drugs because of the lack of relevant knowledge, expertise and treatment for rare diseases limited patient numbers.
Rare diseases are defined as diseases with a particularly low prevalence affecting the lives of individual. In the UK alone this affects around 3 million people. Hence, the diagnosis and treatment of rare diseases is a global issue requiring cross border strategic partnerships to ensure the continuing development of new medicines to treat these diseases.
A rare disease lawyer will be able to advise and assist you if you are at the stage of R&D on rare diseases to bring to market treatments and therapies or supplying and distributing medicines such as orphan medicinal products to treat rare diseases.
|
Related Areas